Where it comes from
- Made in
- The gut wall and skin before birth; brain, gut and kidney after
- Sent out by
- During the migration of neural crest cells into gut and skin
- Acts on
- Neural crest cells
- Enteric neurons
- Melanocytes
What it does
In medicine
- Mutations of EDN3 or its receptor cause Hirschsprung disease (a colon without nerves) and Waardenburg syndrome type 4, with a white forelock and deafness 1
- Those mutations are rare. EDN3 and EDNRB together account for only a small share of Hirschsprung disease, most of which traces to RET 1
- No medicine acts on it deliberately. Bosentan and macitentan block the ETB receptor it prefers, and whether that matters to the gut of an adult has never been studied 3
Beyond the body’s own use
- In melanoma the ETB receptor helps the tumour spread, and blocking it slows melanoma cells in the laboratory; no endothelin blocker has shown benefit in a melanoma trial, and the current work is on antibodies that use the receptor as a target rather than block it 2
- The same signal that places melanocytes before birth keeps them alive afterwards, which is why ETB turns up in work on greying hair and vitiligo; none of that has produced a treatment
- Nothing is in trials, and endothelin-3 has no use beyond the laboratory: a peptide whose main job finishes before birth has little to offer an adult
Sources
- Edery et al., Mutation of the endothelin-3 gene in Waardenburg-Hirschsprung disease, Nature Genetics 1996
- Bagnato et al., Endothelin B receptor blockade inhibits cell interactions in melanoma cell progression, Cancer Research 2004
- Davenport et al., Update on endothelin receptor nomenclature, Pharmacological Reviews 2002
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.